Safety of and interactions between current treatments for asthma and COPD

Thematic Poster Session
Chairs: Paola Rogliani (Rome, Italy), Fabrizio Luppi (Spilamberto, Italy), Dragos Bumbacea (Bucarest, Romania), Maria Gabriela Belvisi (London, United Kingdom)

Safety of tiotropium in patients with cardiac events in the TIOSPIR™ trial Robert Wise (Baltimore, United States of America), Robert Wise, Andy Fowler, Norbert Metzdorf, Helen Dewberry, Achim Mueller, Peter Kowey
Safety of tiotropium in patients with cardiac events in the UPLIFT® trial Donald Tashkin (Los Angeles, United States of America), Donald Tashkin, Andy Fowler, Norbert Metzdorf, Helen Dewberry, Achim Mueller, Marc Decramer
Bronchodilator effect of high strength extrafine BDP/formoterol delivered via NEXThaler® in asthmatics Mario Scuri (Parma, Italy), Brian Leaker, Adeep Puri, Mario Scuri, Sara Collarini, Annalisa Piccinno, Elena Carzana, Silvia Geraci, Dave Singh
Cardiovascular safety of extrafine beclomethasone/formoterol (BDP/FF) delivered via a novel dry powder inhaler (NEXThaler®) in COPD patients Mario Scuri (Parma, Italy), Dave Singh, Giorgia Ciurlia, Annalisa Piccinno, Anna Compagnoni, Maria Bocchi, Mario Scuri
Overall and cardiovascular safety of aclidinium/formoterol fixed-dose combination versus salmeterol/fluticasone in patients with COPD Jutta Beier (Wiesbaden, Germany), Jutta Beier, Claus Vogelmeier, Robert Mroz, Sergi Pascual, Rosa Maria Segarra, Alejhandra Lei, Gonzalo De Miquel
Efficacy and safety of QVA149 compared with salmeterol/fluticasone combination (SFC) in Chinese patients with moderate-to-severe COPD: A subgroup analysis from the LANTERN study Nan Shan Zhong (Guangzhou, China), Nanshan Zhong, Changzheng Wang, Xiangdong Zhou, Nuofu Zhang, Francesco Patalano, Michael Humphries, Linda Wang, Donald Banerji
Safety and effectiveness of indacaterol in Korean COPD patients: A post-marketing surveillance (PMS) study Yeon Oh (Seoul, Republic of Korea), Ho-Kee Yum, Hak-Ryul Kim, Yoon-Soo Chang, Kyeong-Cheol Shin, Yeon-Mok Oh, Song Kim
Effects of the new ultra-long-acting β2-AR agonist indacaterol in chronic treatment alone or in combination with the β1-AR blocker metoprolol on cardiac remodelling Luigino Calzetta (Rome, Italy), Luigino Calzetta, Barbara Rinaldi, Maria Donniacuo, Eugenio Martuscelli, Augusto Orlandi, Maria Gabriella Matera
Searching for synergistic interaction between aclidinium (ACL) and formoterol (FOR): From bench to bedside Luigino Calzetta (Rome, Italy), Luigino Calzetta, Josuel Ora, Paola Rogliani, Maria Gabriella Matera, Mario Cazzola
Lung function with aclidinium/formoterol fixed-dose combination: Pooled analysis of two phase III studies in COPD Dave Singh (Manchester, United Kingdom), Dave Singh, Anthony D. D’Urzo, James F. Donohue, Ferran Chuecos, Anne Leselbaum, Esther Garcia Gil
Efficacy of tiotropium and olodaterol fixed-dose combination in patients with COPD on β-blockers Eric Derom (Gent, Belgium), Eric Derom, Stephanie Korn, Alan Hamilton, Valeria C. Amatto, Yihua Zhao, François Maltais
Comparison of protective effect of bronchodilators in COPD Irina Trofimenko (Irkutsk, Irkutsk Oblast, Russian Federation), Irina Trofimenko, Boris Chernyak
Effects of extra fine formoterol or coarse particle salmeterol on impulse oscillometry (IOS) in corticosteroid treated persistent asthmatics Arvind Deva Manoharan (Dundee, United Kingdom), Arvind Manoharan, Alexander Von Wilamowitz-Moellendorff, Ashley Morrison, Brian Lipworth
Budesonide augments formoterol-induced bronchodilation of human small airways within minutes Reynold Panettieri (Philadelphia, United States of America), Cynthia Koziol-White, Jie Zhang, Anna Miller-Larsson, Ian Dainty, Reynold Panettieri
Safety of bi-weekly infusion of A1-PI augmentation therapy in RAPID Niels Seersholm (Copenhagen, Denmark), Niels Seersholm, Robert Sandhaus, Kenneth R. Chapman, Jonathan Burdon, Eeva Piitulainen, James Stocks, Michael Tortorici, Tanja Rosenberg, Oliver Vit, Martin Bexon, Jonathan Edelman, N. Gerard McElvaney
The add-on effect of tiotropium bromide to ICS/LABA combination inhaler for the patients with severe uncontrolled asthma Masayuki Hojo (Tokyo, Japan), Masayuki Hojo, Motoyasu Iikura, Haruhito Sugiyama, Toshihiro Shirai
Clinically important deterioration in patients with COPD using umeclidinium/vilanterol, tiotropium or placebo: Pooled data M. Reza Maleki-Yazdi (Toronto, Canada), M. Reza Maleki-Yazdi, Dave Singh, Antonio Anzueto, Lee Tombs, Ian Naya, Stephanie Harris, Ahmar Iqbal
Effect of a 10-day oral corticosteroid course on hemostasis and inflammation in patients with stable asthma Christof J. Majoor (Baarn, Netherlands), Christof Majoor, Marlous Sneeboer, Anne De Kievit, Joost Meijers, Tom Van der Poll, Rene Lutter, Pieter Willem Kamphuisen, Elisabeth Bel
In vitro analysis of bronchodilators effect on peroxide lipid oxidation Usman Farkhutdinov (Ufa, Republic of Bashkortostan, Russian Federation), Usman Farkhutdinov, Shamil Farkhutdinov, Valeriy Petriakov
Glucose and lactate concentrations in the distal lung are modified by hyperglycaemia and inflammation Annika Åstrand (Mölndal, Sweden), Cecilia Nagorny Holmberg, Cecilia Wingren, Annika åstrand, John Taylor, James Garnett, Emma Baker, Deborah Baines